Start with its own history
At 20.48×, PDCO is 12.5% above its 9-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

Current valuation, historical context, and peer comparisons.
Current P/E ratio
20.48×
12.5% abovethe 9-observation annual average
Price and EPS in quote currency. Calculation details
Investors are paying 20.48 for every 1 of reported earnings per share.
Annual period-end data · 25 observations
| Period end | P/E | Change |
|---|---|---|
| Apr 27, 2024 | 12.88× | +1.7% |
| Apr 29, 2023 | 12.67× | -14.0% |
| Apr 30, 2022 | 14.72× | -25.3% |
| Apr 30, 2021 | 19.72× | N/M |
| Apr 25, 2020 | N/M | N/M |
| Apr 27, 2019 | 24.33× | +122.2% |
| Apr 28, 2018 | 10.95× | -55.7% |
| Apr 29, 2017 | 24.72× | +10.0% |
| Period end | P/E | Change |
|---|---|---|
| Apr 30, 2016 | 22.46× | +5.3% |
| Apr 25, 2015 | 21.32× | +3.7% |
| Apr 26, 2014 | 20.56× | +11.9% |
| Apr 27, 2013 | 18.37× | +4.3% |
| Apr 28, 2012 | 17.61× | -3.1% |
| Apr 30, 2011 | 18.17× | +1.8% |
| Apr 30, 2010 | 17.85× | +52.5% |
| Apr 25, 2009 | 11.71× | -40.6% |
| Apr 26, 2008 | 19.71× | -17.4% |
| Apr 28, 2007 | 23.87× | +5.5% |
| Apr 29, 2006 | 22.63× | -40.0% |
| Apr 30, 2005 | 37.72× | +12.7% |
| Apr 30, 2004 | 33.48× | +52.5% |
| Apr 26, 2003 | 21.95× | -30.2% |
| Apr 27, 2002 | 31.46× | +15.5% |
| Apr 28, 2001 | 27.23× | +8.7% |
| Apr 29, 2000 | 25.06× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
PDCO This stockPatterson Companies, Inc. | 20.48× |
KDNYChinook Therapeutics, Inc. | N/M |
MORMorphoSys AG | N/M |
MORFMorphic Holding, Inc. | N/M |
MYOVMyovant Sciences Ltd. | N/M |
AMEDAmedisys, Inc. | 76.51× |
PRVBProvention Bio, Inc. | N/M |
ONEM1Life Healthcare, Inc. | N/M |
OLKOlink Holding AB (publ) | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
At 20.48×, PDCO is 12.5% above its 9-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
The median of the 1 positive peer ratios above is 76.51×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore Wisesheets=WISE("PDCO", "PE Ratio", "LQ")Share price 31.33 ÷ EPS 1.53 = 20.48×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Not supplied; this is not a real-time trading quote.
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
The essentials behind the numbers.